Skip to content

Category: In the News

National Journal – Cancer Rates Slope Down in U.S.

By MAGGIE FOX Death rates from cancer continue a slow but steady march downward in the United States, with a few exceptions, the American Cancer Society reported on Wednesday. The group estimates that the reduction translates to a million lives saved since 1990. The American Cancer Society’s annual report shows that between 2004 and 2008,…

FierceBiotech – Spike in approvals can't quell industry protests about FDA

By JOHN CARROLL Throughout 2011 you could hear a growing chorus in the biopharma industry  complain bitterly about the tougher regulatory challenges facing drug developers. Antibiotics got tougher. Diabetes got tougher. Obesity was always a tough nut to crack, and there were three biotechs this year that showed just how hard it can be. The FDA…

FierceBiotech – Spike in approvals can't quell industry protests about FDA

By JOHN CARROLL Throughout 2011 you could hear a growing chorus in the biopharma industry  complain bitterly about the tougher regulatory challenges facing drug developers. Antibiotics got tougher. Diabetes got tougher. Obesity was always a tough nut to crack, and there were three biotechs this year that showed just how hard it can be. The FDA…

Reuters – Targeted drug side effects add to cancer costs

By GENEVRA PITTMAN The average cost of treating each cancer patient who came into a dermatology clinic with skin, hair and nail complaints was almost $2,000, researchers reported this week. That included expenses related to doctors’ appointments, dermatology medications and lab tests. Some patients with skin problems may have to delay or alter their treatment…

Reuters – Targeted drug side effects add to cancer costs

By GENEVRA PITTMAN The average cost of treating each cancer patient who came into a dermatology clinic with skin, hair and nail complaints was almost $2,000, researchers reported this week. That included expenses related to doctors’ appointments, dermatology medications and lab tests. Some patients with skin problems may have to delay or alter their treatment…

WSJ – ‘War on Cancer’ Celebrates 40th Anniversary; What’s Next?.

By KATHERINE HOBSON The National Cancer Act — also known as the war on cancer — celebrates its 40th anniversary today. If you want to take a quick spin through the highlights of progress against the disease over those four decades, the American Society of Clinical Oncology has put together a timeline of major milestones,…

WSJ – ‘War on Cancer’ Celebrates 40th Anniversary; What’s Next?.

By KATHERINE HOBSON The National Cancer Act — also known as the war on cancer — celebrates its 40th anniversary today. If you want to take a quick spin through the highlights of progress against the disease over those four decades, the American Society of Clinical Oncology has put together a timeline of major milestones,…

FierceBiotech – Spike in approvals can't quell industry complaints about FDA

By JOHN CARROLL Throughout 2011 you could hear a growing chorus in the biopharma industry  complain bitterly about the tougher regulatory challenges facing drug developers. Antibiotics got tougher. Diabetes [1] got tougher. Obesity [2] was always a tough nut to crack, and there were three biotechs this year that showed just how hard it can be.…

FierceBiotech – Spike in approvals can't quell industry complaints about FDA

By JOHN CARROLL Throughout 2011 you could hear a growing chorus in the biopharma industry  complain bitterly about the tougher regulatory challenges facing drug developers. Antibiotics got tougher. Diabetes [1] got tougher. Obesity [2] was always a tough nut to crack, and there were three biotechs this year that showed just how hard it can be.…

NYT – Scientific Panel Finds Few Clear Environmental Links to Breast Cancer

By DENISE GRADY An exhaustive new report meant to address public fears about possible links between breast cancer and the environment findsevidence strong enough to make only a few firm recommendations, most already well known and none with a large proven benefit. The most consistent data suggest that women can reduce their risk by avoiding…